We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+22.63%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$204M
AUM Growth
+$30.9M
Cap. Flow
-$2.26M
Cap. Flow %
-1.11%
Top 10 Hldgs %
61.97%
Holding
50
New
4
Increased
19
Reduced
22
Closed
–

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$509K
2
DIS icon
Walt Disney
DIS
+$241K
3
CVX icon
Chevron
CVX
+$212K
4
MSFT icon
Microsoft
MSFT
+$206K
5
SLB icon
SLB Ltd
SLB
+$200K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.35M
2
GILD icon
Gilead Sciences
GILD
+$907K
3
ABBV icon
AbbVie
ABBV
+$706K
4
ISRG icon
Intuitive Surgical
ISRG
+$164K
5
BIIB icon
Biogen
BIIB
+$142K

Sector Composition

Rank Sector Weight
1 Healthcare 30.39%
2 Consumer Discretionary 28.85%
3 Technology 25.26%
4 Communication Services 11.08%
5 Industrials 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
26
Biogen
BIIB
$29.5B
$2.21M 1.08%
9,342
-450
-5% -$142K
BA icon
27
Boeing
BA
$167B
$1.72M 0.84%
4,512
-22
-0.5% -$8.47K
HD icon
28
Home Depot
HD
$335B
$1.04M 0.51%
5,423
+233
+4% +$42.7K
NEE icon
29
NextEra Energy
NEE
$185B
$925K 0.45%
19,148
+548
+3% +$25.1K
NSC icon
30
Norfolk Southern
NSC
$77.1B
$856K 0.42%
4,580
-47
-1% -$8.13K
ABT icon
31
Abbott
ABT
$182B
$835K 0.41%
10,451
-620
-6% -$46.1K
LLY icon
32
Eli Lilly
LLY
$1.07T
$739K 0.36%
5,693
+125
+2% +$15.2K
JNJ icon
33
Johnson & Johnson
JNJ
$641B
$696K 0.34%
4,981
+146
+3% +$19.6K
BMY icon
34
Bristol-Myers Squibb
BMY
$128B
$557K 0.27%
11,671
-100
-0.8% -$4.98K
PFE icon
35
Pfizer
PFE
$141B
$553K 0.27%
13,725
+290
+2% +$11.6K
MRK icon
36
Merck
MRK
$323B
$538K 0.26%
6,783
+110
+2% +$8.23K
T icon
37
AT&T
T
$167B
$430K 0.21%
18,168
+358
+2% +$8.23K
JPM icon
38
JPMorgan Chase
JPM
$947B
$423K 0.21%
4,174
-30
-0.7% -$3.09K
PAYX icon
39
Paychex
PAYX
$41.1B
$415K 0.2%
5,180
– –
COST icon
40
Costco
COST
$422B
$352K 0.17%
1,455
+60
+4% +$13.1K
NUE icon
41
Nucor
NUE
$56.4B
$320K 0.16%
5,486
-60
-1% -$3.52K
VZ icon
42
Verizon
VZ
$198B
$276K 0.14%
4,669
– –
TROW icon
43
T. Rowe Price
TROW
$25.5B
$275K 0.13%
2,750
– –
CAT icon
44
Caterpillar
CAT
$402B
$267K 0.13%
1,974
+25
+1% +$3.32K
DUK icon
45
Duke Energy
DUK
$100B
$242K 0.12%
2,686
– –
DIS icon
46
Walt Disney
DIS
$168B
$239K 0.12%
+2,153
New +$241K
DE icon
47
Deere & Co
DE
$169B
$230K 0.11%
1,440
– –
MSFT icon
48
Microsoft
MSFT
$2.89T
$223K 0.11%
+1,887
New +$206K
CVX icon
49
Chevron
CVX
$378B
$221K 0.11%
+1,795
New +$212K
SLB icon
50
SLB Ltd
SLB
$76.5B
$201K 0.1%
+4,624
New +$200K
1
2

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return
VM
Venator Management Pittsburgh, Pennsylvania $416M AUM 16.01% 1-Year Est. Return

Bender Robert & Associates's Q1 2019 Portfolio in Review

As of Q1 2019, Bender Robert & Associates held 50 positions worth $204M, up 18% from $173M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Bender Robert & Associates's Q1 2019 filing shows 4 new, 19 increased and 22 reduced positions. Its largest new stake was Walt Disney: 2,153 shares worth $239K. The largest sale was Celgene Corp, an estimated $1.35M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bender Robert & Associates's largest Q1 2019 buy was Walt Disney: 2,153 shares worth $239K.
  • Bender Robert & Associates added most to NVIDIA in Q1 2019, an estimated $509K increase.
  • Bender Robert & Associates's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $1.35M.
  • Bender Robert & Associates's ten largest holdings make up 62% of its $204M portfolio in Q1 2019.
  • Bender Robert & Associates opened 4 new positions and closed 0 in Q1 2019.
  • Bender Robert & Associates's portfolio value rose 18% quarter-over-quarter to $204M.

Based on Bender Robert & Associates's 13F filing for Q1 2019, filed 30 Apr 2019.